SCHEMBL394928

SCHEMBL394928

COC(=O)C(C)N(C(=O)c1ccno1)c1c(C)cccc1C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.57
MEN1 O00255 1/20 0.57
PLA2G1B P04054 1/20 0.57
HTT P42858 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
ATG4B Q9Y4P1 1/20 0.57
HPGD P15428 3/20 0.40
HSD17B10 Q99714 3/20 0.40
NPC1 O15118 2/20 0.40
LMNA P02545 1/20 0.40
RORC P51449 3/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
S1PR4 O95977 1/20 0.38
GAA P10253 3/20 0.36
GFER P55789 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL394927 1.00 KMT2A (0.57) KMT2AMEN1PLA2G1BHTTNPSR1
SCHEMBL18419940 0.87 KMT2A (0.45) KMT2AMEN1PLA2G1BHTTNPSR1
SCHEMBL7264107 0.87 KMT2A (0.45) KMT2AMEN1PLA2G1BHTTNPSR1
SCHEMBL6238073 0.87 KMT2A (0.46) KMT2AMEN1PLA2G1BHTTNPSR1
SCHEMBL11154441 0.87 KMT2A (0.47) KMT2AMEN1PLA2G1BHTTNPSR1
Furalaxyl SCHEMBL22528 0.80 MEN1 (0.60) KMT2AMEN1PLA2G1BHTTNPSR1
Furalaxyl SCHEMBL54624 0.80 MEN1 (0.60) KMT2AMEN1PLA2G1BHTTNPSR1
Furalaxyl SCHEMBL9661285 0.80 MEN1 (0.60) KMT2AMEN1PLA2G1BHTTNPSR1
SCHEMBL9560351 0.79 KMT2A (0.46) KMT2AMEN1PLA2G1BHTTNPSR1
SCHEMBL8845759 0.79 KMT2A (0.46) KMT2AMEN1PLA2G1BHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 892 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12391729-B2 Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria SPOGEN BIOTECH INC. (US) 2025-08-19 US claimed
US-20240199709-A1 FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA SPOGEN BIOTECH INC (US) 2024-06-20 US claimed
US-11905315-B2 Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria SPOGEN BIOTECH INC. (US) 2024-02-20 US claimed
US-20210179672-A1 FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA GENISYS CREDIT UNION 2021-06-17 US claimed
EP-2533633-B1 FUNGICIDAL MIXTURES LANXESS DISTRIB GMBH (DE) 2017-02-01 EP claimed
WO-2016044655-A2 FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA SPOGEN BIOTECH INC. (US) 2016-03-24 WO claimed
EP-2533633-A2 FUNGICIDAL MIXTURES LANXESS Distribution GmbH (DE) 2012-12-19 EP claimed
EP-2460408-A1 Nematicidal compositions deVGen N.V. (BE) 2012-06-06 EP claimed
US-20110319435-A1 FUNGICIDE MIXTURES LANXESS DISTRIBUTION GMBH (DE) 2011-12-29 US claimed
WO-2011095492-A2 FUNGICIDAL MIXTURES LANXESS DISTRIBUTION GMBH (DE) 2011-08-11 WO claimed
EP-2315522-A2 FORMATE-CONTAINING FUNGICIDE MIXTURES LANXESS Distribution GmbH (DE) 2011-05-04 EP claimed
WO-2010015635-A2 FUNGICIDE MIXTURES LANXESS DISTRIBUTION GMBH (DE) 2010-02-11 WO claimed
US-12630484-B2 Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes SPOGEN BIOTECH INC. (US) 2026-05-19 US disclosed
US-12599649-B2 Bioactive polypeptides for improvements in plant protection, growth and productivity SPOGEN BIOTECH INC. (US) 2026-04-14 US disclosed
US-12599141-B2 Rod-shaped plant viral nanoparticles or virus-like particles for agricultural applications CASE WESTERN RESERVE UNIVERSITY (US) 2026-04-14 US disclosed
US-20250388630-A1 FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA SPOGEN BIOTECH INC (US) 2025-12-25 US disclosed
WO-1997047589-A1 AMINOPHTHALIC ACID DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 1997-12-18 WO disclosed
WO-1997047620-A1 N-SULFONYLIMIDAZOLES USED AS FUNGICIDES BAYER AKTIENGESELLSCHAFT (DE) 1997-12-18 WO disclosed
WO-1997026251-A1 ACYLATED 5-AMINO-1,2,4-THIADIAZOLES AS PESTICIDES AND FUNGICIDES BAYER AKTIENGESELLSCHAFT (DE) 1997-07-24 WO disclosed
WO-1997008135-A1 ACYLAMINOSALICYLIC ACID AMIDES AND THEIR USES AS PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 1997-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630484-B2 Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes ADA, RNGTT, GNPDA1 KMT2A 2052/4885MEN1 3413/4885PLA2G1B 145/4885
US-12599649-B2 Bioactive polypeptides for improvements in plant protection, growth and productivity MAX, VIP, MRTO4 KMT2A 3443/4885MEN1 3270/4885PLA2G1B 1197/4885
US-20250388630-A1 FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA MAX, SEC62, GHITM KMT2A 4694/4885MEN1 2566/4885PLA2G1B 642/4885
US-12599141-B2 Rod-shaped plant viral nanoparticles or virus-like particles for agricultural applications PRNP, PCNP, VIM KMT2A 531/4885MEN1 964/4885PLA2G1B 3211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.